Date Field | Doc. No. | Description (Pages) |
---|
Aug 24, 2023 | 12 | ANSWER to 10 Answer to Complaint, Counterclaim by Array BioPharma Inc..(Dellinger, Megan) (Entered: 08/24/2023) (8) |
Aug 4, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Alexandra D. Valenti, Gabriel Ferrante, and Christopher J. Cassella - filed by Teva Pharmaceuticals, Inc.. (Russell, Andrew) (Entered: 08/04/2023) (7) |
Aug 4, 2023 | 10 | ANSWER to 1 Complaint Affirmative Defenses, COUNTERCLAIM against Array BioPharma Inc. by Teva Pharmaceuticals, Inc..(Russell, Andrew) (Entered: 08/04/2023) (26) |
Aug 4, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals, Inc. filed by Teva Pharmaceuticals, Inc.. (Russell, Andrew) (Entered: 08/04/2023) (2) |
Jun 26, 2023 | N/A | SO ORDERED, re 8 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to August 4, 2023 filed by Teva Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/26/2023. (etg) (Entered: 06/26/2023) (0) |
Jun 22, 2023 | 8 | STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to August 4, 2023 - filed by Teva Pharmaceuticals, Inc.. (Keller, Karen) (Entered: 06/22/2023) (1) |
Jun 14, 2023 | 7 | SUMMONS Returned Executed by Array BioPharma Inc..Teva Pharmaceuticals, Inc. served on 6/14/2023, answer due 7/5/2023. (Dellinger, Megan) (Entered: 06/14/2023) (2) |
Jun 14, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 06/14/2023) (0) |
Jun 8, 2023 | 1 | COMPLAINT filed against Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4154119.) - filed by Array BioPharma Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(smg) (Entered: 06/08/2023) (Main Document) (11) |
Jun 8, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) (Entered: 06/08/2023) (3) |
Jun 8, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/09/2022. Date of Expiration of Patent: 10/18/2033. (smg) (Entered: 06/08/2023) (1) |
Jun 8, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,562,016 B2; 9,598,376 B2; 9,980,944 B2. (smg) (Entered: 06/08/2023) (1) |
Jun 8, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Array BioPharma Inc. filed by Array BioPharma Inc. (smg) (Entered: 06/08/2023) (1) |
Jun 8, 2023 | 6 | Summonses Issued (please complete the top portion of the form and print out for use/service). (smg) (Entered: 06/08/2023) (2) |
Jun 8, 2023 | 1 | COMPLAINT filed against Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4154119.) - filed by Array BioPharma Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(smg) (Entered: 06/08/2023) (Exhibit A) (30) |
Jun 8, 2023 | 1 | COMPLAINT filed against Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4154119.) - filed by Array BioPharma Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(smg) (Entered: 06/08/2023) (Civil Cover Sheet) (1) |